Life Technologies, Enzo Biochem Settle Patent Infringement Lawsuit | GenomeWeb

NEW YORK (GenomeWeb) – Enzo Biochem said today that it has reached a settlement with Thermo Fisher Scientific's Life Technologies business on two patent infringement lawsuits.

Thermo Fisher will pay Enzo $35 million to settle the claims Enzo filed in Delaware Federal District Court in 2012. Enzo claimed Life Tech infringed on two patents — No. 6,992,180, entitled Oligo- or Polynucleotides Comprising Phosphate Moiety Labeled Nucleotides, and No. 7,064,197, entitled System, Array and Non-Porous Solid Support Comprising Fixed or Immobilized Nucleic Acids.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.